共 50 条
Bamboo Joint-Like Appearance of the Stomach: A Stable Endoscopic Landmark for Crohn's Disease Regardless of Anti-Tumor Necrosis Factor alpha Treatment
被引:0
|作者:
Hashiguchi, Keiichi
[1
]
Takeshima, Fuminao
[1
]
Akazawa, Yuko
[1
]
Matsushima, Kayoko
[1
]
Minami, Hitomi
[1
]
Yamaguchi, Naoyuki
[1
]
Shiozawa, Ken
[1
]
Ohnita, Ken
[1
]
Ichikawa, Tatsuki
[1
]
Isomoto, Hajime
[1
]
Nakao, Kazuhiko
[1
]
机构:
[1] Nagasaki Univ, Grad Sch Biomed Sci, Dept Gastroenterol & Hepatol, Nagasaki 852, Japan
来源:
MEDICAL SCIENCE MONITOR
|
2014年
/
20卷
关键词:
Crohn's Disease;
Diagnosis;
Endoscopy;
Gastrointestinal;
UPPER GASTROINTESTINAL-TRACT;
INFLAMMATORY-BOWEL-DISEASE;
GASTRIC BODY;
INFLIXIMAB;
CHILDREN;
THERAPY;
LESIONS;
CARDIA;
TRIAL;
D O I:
暂无
中图分类号:
R-3 [医学研究方法];
R3 [基础医学];
学科分类号:
1001 ;
摘要:
Background: Bamboo joint-like appearance is a common yet easy-to-miss endoscopic finding in the stomach of patients with Crohn's disease (CD). Bamboo joint-like appearance (BJA) is characterized by swollen longitudinal folds transversed by erosive fissures or linear furrows. However, whether BJA is observed during the remission stage of CD and during the active stage is unclear. In particular, the relationship between the course of BJA and anti-tumor necrosis factor (TNF) alpha therapy has not been studied. We aimed to evaluate the course of BJA in CD patients treated with anti-TNF alpha therapy. Material/Methods: We examined 22 CD patients who underwent esophagogastroduodenal endoscopy before undergoing anti-TNF a treatment. We evaluated the changes in BJA, clinical activity using the CD activity index (CDAI), and endoscopic activity using the simple endoscopic score for CD (SES-CD) from 6 months to 1 year after anti-TNF alpha therapy. Results: Fifteen of 22 patients (68.1%) presented with BJA in the stomach, 13 of whom received follow-up esophagogastroduodenal endoscopy after anti-TNF alpha therapy. The mean CDAI and SES-CD scores significantly improved after anti-TNF alpha therapy (P<0.01). Despite the marked improvements in clinical and endoscopic findings, the BJA of the stomach remained unchanged in all the patients. Conclusions: The findings indicate that BJA is frequently observed in the stomach of CD patients, regardless of whether the patient has active disease or is in remission, even after anti-TNF alpha therapy. Thus, BJA may be a stable endoscopic landmark in CD.
引用
收藏
页码:1918 / 1924
页数:7
相关论文